Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2025-12-26 @ 1:13 AM
NCT ID: NCT00682734
Description: None
Frequency Threshold: 0.1
Time Frame: None
Study: NCT00682734
Study Brief: Metoclopramide for Migraine: A Dose Finding Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Metoclopramide 10 mg Intravenous Metoclopramide 10 mg intravenous + diphenhydramine 25 mg intravenous None None 0 113 8 113 View
Metoclopramide 20 mg Metoclopramide 20mg intravenous+ diphenhydrmaine 25 mg intravenous None None 1 118 8 118 View
Metoclopramide 40 mg Metoclopramide 40 mg intravenous + diphenhdyramine 25 mg intravenous None None 0 118 7 118 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Encephalitis None Nervous system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Akathisia None Nervous system disorders None View